TABLE 1.

Example of Molecules With Test Data Exclusivity in 3 Central American Countries, May 2008

Molecule	Indication or Description	El Salvador	Nicaragua	Guatemala
Nesiritide	Acute cardiac arrest	X		X
Rimonabant	Obesity	X		X
Paliperidone	Antipsychotic	X		X
Tigecicline	Antibiotic	X		X
Proteins L1 (types 6, 11, 16, 18)	Vaccine for human papilloma virus	X		X
Sorafenib	Cancer	X		X
Erlotinib	Cancer	X		X
Sunitinib	Cancer	X		X
Drosperinone + etinilestradiol	Oral contraceptive	X		X
Maraviroc	AIDS		X	X
Desvenlafaxine	Antidepressant		X	X
Bevacizumab	Cancer		X	X
Sitagliptine	Diabetes	X	X	X
Varenicline	Smoking cessation	X	X	X
Bortezomib	Cancer	X
Aliskiren	High blood pressure	X
Protein variants G1, 2, 3, 4, P1	Vaccine for HIV	X
Vidagliptine	Diabetes	X
Deferasirox	Iron overload	X
Insulin lispro	Diabetes	X
M-polyethylene-glycol-epoetin β	Chronic anemia	X
Doripenem	Antibiotic	X

Note. For space reasons, not all of the drugs protected in Guatemala (98 drugs) are shown. The entire lists for Nicaragua (5 drugs) and El Salvador (19 drugs) are shown. Costa Rica did not have any drugs with data protection at the time of the study.

Source. E. Espinoza et al., unpublished data, December 2009; D. Quintero and C. Berríos, unpublished data, January 2010; A. Moreno and C. García, unpublished data, December 2009.